Patient advocacy groups’ perception of pharma companies fell for the first time since beginning a steady rise five years ago, a sign that the industry may not be able to fully hang on to the improved reputation it’s enjoyed over the last several years, according to a new survey.
The…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
